Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
F. Çiftci (Ankara, Turkey). The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion. 365

Member's Comments

No comment yet.

Related content which might interest you: Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020 The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Role of serum and pleural fluid NT-proBNP levels in identifying pleural effusion due to heart failure Source: Annual Congress 2008 - Pleural effusion Year: 2008 The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Pleural fluid procalcitonin levels in identifying pleural effusions due to infection Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Pleural fluid leptin level for the differential diagnosis of pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Homocysteine levels in pleural effusion etiology Source: Eur Respir J 2007; 30: Suppl. 51, 89s Year: 2007 Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003 Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion Source: Annual Congress 2008 - Pleural effusion Year: 2008 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Comparison and relationship of cholesterol and lipoproteins of pleural effusions with serum levels of them in exudative and transudative pleural fluid Source: Eur Respir J 2005; 26: Suppl. 49, 446s Year: 2005 Is it important to determine pleural fluid amylase in patients with malignant pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Pleural fluid and plasma D-dimer levels tuberculous pleurisy: the diagnostic value and relation with clinical parameters Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019